SUBSCRIBE
SUBSCRIBE

North Carolina

Facade of the FDA's office in Maryland
Policy
FDA Puts Clinical Hold on Three CARsgen Therapeutics CAR-T Candidates
The regulator placed the clinical hold on the Chinese biotech’s trio of CAR-T cell therapy candidates after an inspection of its Durham, North Carolina manufacturing facility.
December 15, 2023
 · 
2 min read
 · 
Tyler Patchen
Courtesy of Cristina Arias/Getty Images
Job Trends
New Lilly Manufacturing Plant to Bring 600 Jobs to North Carolina
Eli Lilly and Company announced plans to build a new manufacturing plant in Concord, North Carolina.
January 31, 2022
 · 
2 min read
 · 
Mark Terry
Load More
PRESS RELEASES
Press Releases
FUJIFILM Diosynth Biotechnologies and Regeneron Sign a 10-Year U.S. Manufacturing Agreement Valued at Over $3 Billion
April 22, 2025
 · 
5 min read
Press Releases
BioCryst to Report First Quarter 2025 Financial Results on May 5
April 22, 2025
 · 
1 min read
Press Releases
IQVIA to Announce First-Quarter 2025 Results on May 6, 2025
April 22, 2025
 · 
2 min read
Press Releases
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference
April 21, 2025
 · 
5 min read
Press Releases
Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies
April 21, 2025
 · 
9 min read
Press Releases
United Therapeutics Corporation to Report First Quarter 2025 Financial Results Before Market Open on Wednesday, April 30, 2025
April 16, 2025
 · 
2 min read
Press Releases
Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call
April 16, 2025
 · 
1 min read
Press Releases
Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
April 16, 2025
 · 
4 min read
Press Releases
Belhaven Biopharma Announces Positive Data From Their Nasdepi(R) Dose Confirmation Study in Patients With and Without Allergic Rhinitis
April 15, 2025
 · 
3 min read
Press Releases
Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B
April 15, 2025
 · 
9 min read
Press Releases
Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update
April 15, 2025
 · 
1 min read
Press Releases
Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition from Coherus BioSciences, Inc., Expanding U.S. Biosimilar Portfolio
April 14, 2025
 · 
9 min read
Press Releases
Evecxia Therapeutics Announces Appointment Of C.R. Sincock II To The Board Of Directors
April 10, 2025
 · 
1 min read
Press Releases
Merakris Therapeutics Appoints Roger Ilagan to Chief Scientific Officer
April 10, 2025
 · 
4 min read
Press Releases
Dentsply Sirona to Host First Quarter Conference Call on May 8th
April 9, 2025
 · 
1 min read
Press Releases
Merz Aesthetics® Announces Salma Hayek Pinault as First-Ever Global Brand Ambassador for Ultherapy PRIME®, the Next Generation Platform for Nonsurgical Skin Lifting Treatments
April 9, 2025
 · 
5 min read
Press Releases
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
April 9, 2025
 · 
13 min read
Press Releases
Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial
April 8, 2025
 · 
2 min read
Press Releases
Adaptin Bio, Inc., a Lucius Partners Portfolio Company, Completes Alternative Public Offering (APO) and Closes $7.7 Million Private Placement
April 7, 2025
 · 
6 min read
Press Releases
Opus Genetics Files Definitive Proxy Statement and Sends Letter to Stockholders Highlighting the Company’s Transformation and Progress
April 7, 2025
 · 
12 min read
Load More